GB/T 18672-2002
Replaced
T/CACM 1315-2019
Active
Group standards
T/CACM 1315-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Alzheimer's Disease
T/CACM 1315-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Alzheimer's Disease
Price:
$ 20.00
Basic Information
Standard Code:
T/CACM 1315-2019
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medicine
ICS Name:
Comprehensive Pharmaceutical Science
Publish Date:
2019-01-30
Implement Date:
2020-01-01
Scope
Main technical content: This guideline provides recommendations for the diagnosis, differential diagnosis, treatment, prevention, and care of Alzheimer's disease. This guideline is applicable to the diagnosis and prevention of Alzheimer's disease in people over the age of 40. This guideline is suitable for clinicians in geriatrics, neurology, and traditional Chinese medicine departments of general hospitals, etc.
Development Information
Related Standards
GB/T 19116-2003
Abolished
GB/T 19116-2003 Lycium culture technics operatings
GB 19742-2005
Replaced
GB 19742-2005 Product of designations of origin or geographical Indication—Ningxia Lycium
LY/T 1778-2008
Abolished
LY/T 1778-2008 Technical regulation for planting bulbus fritillariae
GB/T 18672-2014
Active
GB/T 18672-2014 Wolfberry
GB/T 35476-2017
Active